Exploring Dosilicon Co., Ltd. Investor Profile: Who’s Buying and Why?

Exploring Dosilicon Co., Ltd. Investor Profile: Who’s Buying and Why?

CN | Technology | Semiconductors | SHH

Dosilicon Co., Ltd. (688110.SS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Who is backing Dosilicon Co., Ltd. and why does it matter to investors now that institutional ownership totals a hefty footprint? With Dongfang Hengxin Group Co., Ltd. holding a commanding 31.50% stake as of October 10, 2025, and other institutions owning 46.28% of shares alongside public companies and retail investors at 43.30%, the ownership structure is both concentrated and broadly supported; add the company's 20.80% revenue growth in 2024 and a market capitalization of 48.73 billion CNY (as of December 17, 2025) against a trailing twelve-month net loss of 182.99 million CNY, and you get a complex investor profile worth unpacking-especially given Dosilicon's strategic move into Shanghai Lisuan Technology Co., Ltd. and its focus on NAND flash, NOR flash, and DRAM chips with 434.74 million total shares outstanding.

Dosilicon Co., Ltd. (688110.SS) - Who Invests in Dosilicon Co., Ltd. and Why?

Dosilicon attracts a mix of strategic, institutional and retail capital driven by its market position in memory chips (NAND, NOR, DRAM) and recent operational momentum.
  • Strategic investors: Dongfang Hengxin Group Co., Ltd. holds 31.50% as of October 10, 2025, signaling long-term industrial backing and influence over corporate strategy.
  • Institutional investors: asset managers and funds target Dosilicon for exposure to China's memory semiconductor supply chain and revenue growth potential.
  • Retail investors: drawn by visible growth metrics and the stock's liquidity within the STAR Market (688110.SS).
  • Strategic/VC partners: companies and funds interested in vertical integration, IP access and acceleration of product roadmaps-e.g., the strategic investment in Shanghai Lisuan Technology Co., Ltd. to boost competitiveness.
  • Primary investment rationales
  • Revenue momentum: 20.80% year-over-year increase in 2024 suggests expanding sales and market traction.
  • Product exposure: leadership in NAND flash, NOR flash and DRAM taps into persistent global memory demand and industry cycles.
  • Scale and market value: market capitalization reached 48.73 billion CNY as of December 17, 2025, offering institutional-scale investment size.
  • Strategic partnerships: investments such as the stake in Shanghai Lisuan enhance technology breadth and go-to-market capabilities.
Metric Value
Largest shareholder (date) Dongfang Hengxin Group Co., Ltd. - 31.50% (as of 2025-10-10)
Market capitalization 48.73 billion CNY (as of 2025-12-17)
Revenue growth +20.80% in 2024 vs 2023
Trailing twelve months net income Net loss of 182.99 million CNY
Core product segments NAND flash, NOR flash, DRAM
Notable strategic investment Shanghai Lisuan Technology Co., Ltd. (strategic stake to enhance competitiveness)
  • Why investors tolerate current losses
  • Revenue growth indicates operating scale expansion that can convert to profitability as margins improve and R&D/production leverage kicks in.
  • Strategic majority holder reduces execution risk and signals governmental/industrial support in a strategic sector.
  • Memory market cyclical upside: investors position for upcycles in NAND/DRAM pricing and enterprise demand recovery.
  • Key investor risks considered
  • Near-term profitability pressure: TTM net loss of 182.99 million CNY requires close monitoring of margin trends.
  • Market cyclicality: memory prices and inventory swings can depress revenue momentum.
  • Execution on strategic investments (e.g., Shanghai Lisuan) must deliver integration and product gains to justify valuation.
Dosilicon Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Dosilicon Co., Ltd. (688110.SS) Institutional Ownership and Major Shareholders of Dosilicon Co., Ltd. (688110.SS)

  • Largest institutional shareholder: Dongfang Hengxin Group Co., Ltd. - 31.50% (as of 2025-10-10).
  • Other institutional investors (collective): 46.28% - indicating strong institutional interest.
  • Public companies and retail investors: 43.30% - reflecting a broad retail/public base.
Metric Value Notes
Total shares outstanding 434.74 million Reported total share count
Dongfang Hengxin Group Co., Ltd. 31.50% (≈136.98 million shares) Largest single institutional holder (as of 2025-10-10)
Other institutional investors (collective) 46.28% (≈201.20 million shares) Aggregate institutional stake (per source)
Public companies & retail investors 43.30% (≈188.24 million shares) Broad public/retail participation
Market capitalization (2025-12-17) 48.73 billion CNY Reference market cap date
Implied share price (market cap / shares) ≈112.11 CNY / share Calculated from market cap and outstanding shares
Revenue growth (2024 vs 2023) +20.80% Recent top-line growth cited
  • Why institutions are likely accumulating Dosilicon:
    • Scale and control: Dongfang Hengxin's 31.50% stake provides strategic influence and signals long-term commitment.
    • Institutional momentum: A combined institutional presence (per data) suggests confidence in sector fundamentals and management.
    • Growth trajectory: 20.80% revenue growth in 2024 supports allocation increases by funds seeking growth exposure.
    • Strategic investments: The company's stake in Shanghai Lisuan Technology Co., Ltd. is likely viewed as a catalyst for future value creation by some investors.
Breaking Down Dosilicon Co., Ltd. Financial Health: Key Insights for Investors

Dosilicon Co., Ltd. (688110.SS) Key Investors and Their Impact on Dosilicon Co., Ltd. (688110.SS)

Dosilicon Co., Ltd. (688110.SS) presents a concentrated ownership and strategic-investment profile that materially shapes governance, technology roadmap and investor sentiment.

  • Dongfang Hengxin Group Co., Ltd. - largest shareholder with a 31.50% stake, enabling decisive influence over board composition, capital allocation and strategic direction.
  • Strategic partnership/investment in Shanghai Lisuan Technology Co., Ltd. - positions Dosilicon to accelerate technology transfer and product development in memory-chip processes.
  • Investor appetite is reinforced by the company's product focus on NAND flash, NOR flash and DRAM - categories aligned with secular demand in storage and computing markets.
Metric Value / Note
Largest shareholder Dongfang Hengxin Group Co., Ltd. - 31.50% stake
Strategic investment Investment in Shanghai Lisuan Technology Co., Ltd. (technology & market positioning)
Primary products NAND flash, NOR flash, DRAM
Trailing twelve months (TTM) net income Net loss of 182.99 million CNY
Market capitalization (as of 2025-12-17) 48.73 billion CNY

Investor implications and behaviors:

  • Control investor (Dongfang Hengxin) can drive long-term capital projects and protect against short-term activist pressure due to its 31.50% stake.
  • Strategic tech investments (e.g., Shanghai Lisuan) are likely intended to shore up R&D and IP, which can attract strategic and industry investors prioritizing capability-led value creation.
  • Product alignment with NAND/NOR/DRAM market trends supports a narrative of participation in secular growth segments-this underpins the market cap of 48.73 billion CNY despite recent TTM net loss.
  • Reported TTM net loss of 182.99 million CNY signals near-term profitability risks; however, investors focused on market share expansion and technology momentum may tolerate current losses if revenue growth trajectory continues.

Further reading on the company's financial mechanics and detailed metrics: Breaking Down Dosilicon Co., Ltd. Financial Health: Key Insights for Investors

Dosilicon Co., Ltd. (688110.SS) - Market Impact and Investor Sentiment

Dosilicon's market presence and recent operating dynamics are shaping investor attitudes across institutional and retail channels. Key quantitative signals provide a mixed but directional picture that helps explain who's buying and why.
  • Market capitalization: 48.73 billion CNY (as of 2025-12-17) - a clear indicator of sizeable investor backing and market confidence.
  • Revenue growth: +20.80% in 2024 vs. 2023 - signals accelerating top-line momentum attractive to growth-oriented investors.
  • Trailing twelve months net loss: -182.99 million CNY - a cautionary metric for value and income-focused investors, though manageable relative to market cap.
  • Strategic investment: stake in Shanghai Lisuan Technology Co., Ltd. - viewed by many investors as a catalyst for enhanced competitiveness and vertical integration.
  • Product focus: NAND flash, NOR flash, and DRAM - places Dosilicon squarely in a high-growth semiconductor memory segment sought by thematic and sector-focused funds.
Metric Value Date / Period
Market Capitalization 48.73 billion CNY 2025-12-17
Revenue Growth (YoY) 20.80% 2024 vs. 2023
Net Income (TTM) -182.99 million CNY Trailing Twelve Months
Core Products NAND, NOR, DRAM Ongoing
Strategic Investment Shanghai Lisuan Technology Co., Ltd. (strategic stake) Announced 2024-2025
Investor segmentation and motivations:
  • Growth-focused institutional investors: attracted by double-digit revenue growth and semiconductor memory exposure, betting on scaling and margin recovery.
  • Sector and thematic funds: allocate to Dosilicon for targeted exposure to NAND/NOR/DRAM supply dynamics and secular demand drivers (data centers, mobile, AI workloads).
  • Event-driven and private-equity aligned investors: monitoring the Shanghai Lisuan strategic investment as a trigger for consolidation, IP access, or supply-chain advantages.
  • Risk-conscious retail investors and value funds: cautious due to the recent net loss, but selectively buying on market dips given the sizeable market cap and growth trajectory.
Sentiment signals and market behavior:
  • Price action relative to peers: Dosilicon's market cap and revenue acceleration have led to relative outperformance during positive semiconductor cycles; underperformance observed during macro risk-off periods due to reported losses.
  • Analyst coverage and buy-side notes: increased attention following the Shanghai Lisuan transaction and 2024 revenue beat - contributing to higher buy-side conviction among growth allocators.
  • Volume and ownership trends: elevated institutional stake accumulation correlates with the 48.73 billion CNY market cap milestone, indicating confidence despite near-term unprofitability.
Breaking Down Dosilicon Co., Ltd. Financial Health: Key Insights for Investors

DCF model

Dosilicon Co., Ltd. (688110.SS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.